Palatin Technologies
PTN
#9923
Rank
C$54.1 M
Marketcap
C$31.77
Share price
4.59%
Change (1 day)
2,395.44%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -C$24.03 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$37.22 Million, an increase over its 2023 earnings that were of -C$44.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$24.03 Million-35.44%
2024 -C$37.22 Million-16.9%
2023 -C$44.79 Million5.99%
2022 -C$42.26 Million-13.7%
2021 -C$48.97 Million33.25%
2020 -C$36.75 Million-172.11%
2019 C$50.95 M2352.33%
2018 C$2.07 M-94.13%
2017 C$35.4 M-154.92%
2016 -C$64.47 Million3.67%
2015 -C$62.19 Million878%
2014 -C$6.36 Million-72.64%
2013 -C$23.24 Million-33.11%
2012 -C$34.75 Million77.71%
2011 -C$19.55 Million
2003 -C$33.11 Million29.93%
2002 -C$25.48 Million36.18%
2001 -C$18.71 Million
1999 -C$15.53 Million6.04%
1998 -C$14.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-C$16.32 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$40.74 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.80 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$69.83 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$92.27 M-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$76.75 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.08 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK